VISIT HEALTHCARE PROFESSIONAL SITE

Home
PATIENT PERSPECTIVES
Our Treatments
Patient Services
Find an Event
Sign Up
VISIT HEALTHCARE PROFESSIONAL SITE

Sign Up

Sign up today!

Receive the latest in Rare Blood Disorder news,
educational programs, and other support resources.

All form fields required unless otherwise specified.

First Name

Last Name

Email

Address Line 1

Address Line 2 (optional)

City

State

ZIP Code

Tell us more about who you are

I am living with a rare blood disorder I am a caregiver

Which of the following areas most interest you?

Hemophilia A Hemophilia B Acquired thrombotic thrombocytopenic purpura (aTTP) Immune thrombocytopenia (ITP)

How would you like to be contacted?

Email Phone call Text message

By checking this box, I consent that Sanofi and its third-party business partners (such as marketing agencies and market research firms) may collect, use, and share with one another the information I provide in order to contact me by mail, email, fax, telephone and/or text message, and send me information about rare blood disorders and relevant Sanofi products, promotions, services, and research studies, ask my opinion about such information and topics, including through market research and disease-related surveys, and to de-identify it for use in performing research, education, business analytics, marketing studies, and other commercial purposes. I understand that text messaging rates may apply. Your information will not be sold to any third-party but may be provided to regulatory authorities if required. I may opt out of continued receipt of such communications at any time by emailing RBDPatientSolutions@sanofi.com.

I certify that I am at least 18 years old.

You may have certain rights under applicable data privacy laws regarding the personal information that you provide, including the right to withdraw consent from future collection or sharing of your information. For further information regarding these rights, please reference Sanofi US Privacy Policies and Consumer Health Data Privacy Policy.

chevron-previous

Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

Follow us

Sitemap |
Legal Notice |
Privacy Policy |
Consumer Health Data Privacy Policy |
Contact |
Cookies Policy |

This site is intended for U.S. residents only.

© 2025 Sanofi. All rights reserved.

Sanofi is a registered trademark of Sanofi or an affiliate.

All other trademarks are the property of their respective owners.

MAT-US-2309560-v4.0-09/2025

Now approved

Please See Full Prescribing Information.

Important safety information and indication

Important Safety Information

What is the most important information I need to know about ALTUVIIIO?

Do not attempt to give yourself an injection unless you have been taught how by your healthcare provider or hemophilia center. You must carefully follow your healthcare provider's instructions regarding the dose and schedule for injecting ALTUVIIIO so that your treatment will work best for you.

Who should not use ALTUVIIIO?

You should not use ALTUVIIIO if you have had an allergic reaction to it in the past.

What should I tell my healthcare provider before using ALTUVIIIO?

Tell your healthcare provider if you have had any medical problems, take any medications, including prescription and non-prescription medicines, supplements, or herbal medicines, are breastfeeding, or are pregnant or planning to become pregnant.

What are the possible side effects of ALTUVIIIO?

You can have an allergic reaction to ALTUVIIIO. Call your healthcare provider or emergency department right away if you have any of the following symptoms: difficulty breathing, chest tightness, swelling of the face, rash, or hives.

Your body can also make antibodies called “inhibitors” against ALTUVIIIO. This can stop ALTUVIIIO from working properly. Your healthcare provider may give you blood tests to check for inhibitors.

The common side effects of ALTUVIIIO are headache, joint pain, and back pain.

These are not the only possible side effects of ALTUVIIIO. Tell your healthcare provider about any side effect that bothers you or does not go away.

Indication

ALTUVIIIO^® [antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl] is an injectable medicine that is used to control and reduce the number of bleeding episodes in people with hemophilia A (congenital Factor VIII deficiency).

Your healthcare provider may give you ALTUVIIIO when you have surgery.

Please see full Prescribing Information.

© 2023 Genzyme Corporation. All rights reserved. ALTUVIIIO and Sanofi are trademarks of Sanofi or an affiliate.
MAT-US-2300536-v1.0-03/2023